Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,330 | -35,470 | -28,210 | -22,530 | -24,630 |
| Depreciation Amortization | 9,180 | 6,910 | 4,770 | 2,210 | 1,920 |
| Other Working Capital | 12,260 | 16,010 | 16,050 | 12,690 | 18,380 |
| Other Operating Activity | 3,770 | 5,790 | 7,920 | 7,550 | 3,390 |
| Operating Cash Flow | $-2,120 | $-6,760 | $530 | $-80 | $-940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -880 | -480 | -750 | -690 | -480 |
| Net Acquisitions | 21,600 | 22,530 | 22,530 | 22,280 | -7,270 |
| Other Investing Activity | 18,090 | 34,940 | 35,400 | 14,900 | -39,840 |
| Investing Cash Flow | $38,810 | $56,990 | $57,180 | $36,490 | $-47,590 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,930 | 630 | 630 | 350 | 540 |
| Financing Cash Flow | $1,930 | $630 | $630 | $350 | $540 |
| Exchange Rate Effect | 820 | 530 | -800 | -360 | 0 |
| Beginning Cash Position | 24,370 | 24,370 | 24,370 | 24,370 | 72,360 |
| End Cash Position | 63,820 | 75,770 | 81,920 | 60,770 | 24,370 |
| Net Cash Flow | $39,440 | $51,400 | $57,550 | $36,400 | $-47,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,120 | -6,760 | 530 | -80 | -940 |
| Free Cash Flow | -2,120 | -6,760 | 530 | -80 | -940 |